Large-Scale Real-World Study Develops AI Tool for Ulinastatin Response Prediction in Cardiac Surgery — 10,000-Patient Chinese Cohort

References

1. 1.Beijing Anzhen Hospital. (2024). Development and validation of an AI-based tool for identifying responders and stratifying risks in ulinastatin treatment in cardiac surgery: A multicenter real-world study. ClinicalTrials.gov. NCT07583290. https://clinicaltrials.gov/study/NCT07583290
2. 2.Leng, Y., Xie, J., Jiang, L., Guo, Y., Liu, Y., & Liu, L. (2022). Ulinastatin for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials. Critical Care, 26(1), 180. https://doi.org/10.1186/s13054-022-04053-4
3. 3.Milne, B., Gilbey, T., & Kunst, G. (2019). Perioperative management of the patient for cardiac surgery. Anaesthesia, 74(S1), 67-72. https://doi.org/10.1111/anae.14478
4. 4.Squiccimarro, E., Labriola, C., Malvindi, P. G., Margari, V., Guida, P., Visicchio, G., Kounakis, G., Favale, A., Dambruoso, P., Mastrototaro, G., Lorusso, R., & Paparella, D. (2017). Prevalence and clinical impact of systemic inflammatory reaction after cardiac surgery. Journal of Cardiothoracic and Vascular Anesthesia, 31(4), 1382-1390. https://doi.org/10.1053/j.jvca.2016.11.013
5. 5.Wang, C., Xie, N., Wang, M., Tan, Y., Cai, H., & Wu, Y. (2021). Evaluation of perioperative ulinastatin on postoperative outcomes in cardiac surgery: a meta-analysis. Medicine, 100(44), e27893. https://doi.org/10.1097/MD.0000000000027893